Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089)
in pediatric subjects with partial-onset (focal) seizures following single and
multiple-dosing.